Got a voucher? follow @pedroganco on Instagram to find one this month only!
DirectoryMedium Effortglobal

PeriPath — Symptom-to-Care Navigator for Perimenopause, Built for the “No Single Test” Reality

Perimenopause is a classic “high pain, low clarity” market.

Score77/100
Apr 9, 2026
TAM
€2.4B — European femtech market in 2024, with strong menopause / midlife-health whitespace and projected growth to €9.7B by 2033.
SAM
€240M — a conservative 10% slice of femtech focused on perimenopause/menopause navigation, symptom management, and care coordination.
SOM
€1.0M — 7,000 paid users at ~€12/mo equivalent, or a mix of D2C plus a handful of employer pilots in years 1-2.
EuropeDirectoryAPIHealth

The Problem

Perimenopause is a classic “high pain, low clarity” market.

Women often know something is wrong long before they know what it is. The care system makes this worse: symptoms are broad...

Unlock full report

Get the complete analysis including revenue model, market breakdown, and step-by-step building guide.

Already have an account? Sign in